SCHEMBL1099290

SCHEMBL1099290

CS(=O)(=O)CCN(c1sc2ccccc2c1Cl)S(=O)(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 0.41
CD274 Q9NZQ7 1/20 0.37
MCL1 Q07820 1/20 0.37
KEAP1 Q14145 2/20 0.36
NFE2L2 Q16236 2/20 0.36
LOXL2 Q9Y4K0 1/20 0.35
HSD11B1 P28845 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
OGG1 O15527 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
C1R P00736 1/20 0.34
PRSS1 P07477 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099333 0.86 ALDH1A1 (0.42) TRPM8CD274MCL1KEAP1NFE2L2
SCHEMBL1098670 0.85 TDP1 (0.49) TRPM8CD274KEAP1NFE2L2MAPT
SCHEMBL1099122 0.85 TRPM8 (0.37) TRPM8KEAP1NFE2L2HSD11B1TDP1
SCHEMBL1099757 0.85 LOXL2 (0.43) TRPM8CD274MCL1KEAP1NFE2L2
SCHEMBL1098457 0.84 NR1I2 (0.44) TRPM8MCL1KEAP1NFE2L2LOXL2
SCHEMBL1097946 0.81 S1PR1 (0.48) TRPM8CD274MCL1KEAP1NFE2L2
SCHEMBL1098097 0.81 TRPM8 (0.38) TRPM8CD274MCL1KEAP1NFE2L2
SCHEMBL27789303 0.81 TRPM8 (0.38) TRPM8CD274MCL1KEAP1NFE2L2
SCHEMBL28787763 0.79 TRPM8 (0.42) TRPM8CD274MCL1KEAP1NFE2L2
SCHEMBL1098634 0.78 PKM (0.54) TRPM8KEAP1NFE2L2ALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
CN-101801949-A Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2010-08-11 CN disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885CD274 4856/4885MCL1 3803/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885CD274 4856/4885MCL1 3803/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885CD274 4856/4885MCL1 3803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.